The Role of Genetic Testing in the Identification of Young Athletes with Inherited Primitive Cardiac Disorders at Risk of Exercise Sudden Death. - PubMed - NCBI

The Role of Genetic Testing in the Identification of Young Athletes with Inherited Primitive Cardiac Disorders at Risk of Exercise Sudden Death. - PubMed - NCBI

Front Cardiovasc Med. 2016 Aug 26;3:28. doi: 10.3389/fcvm.2016.00028. eCollection 2016.

The Role of Genetic Testing in the Identification of Young Athletes with Inherited Primitive Cardiac Disorders at Risk of Exercise Sudden Death.

Tiziano FD1, Palmieri V2, Genuardi M1, Zeppilli P2.

Author information

Abstract

Although relatively rare, inherited primitive cardiac disorders (IPCDs) in athletes have a deep social impact since they often present as sudden cardiac death (SCD) of young and otherwise healthy persons. The diagnosis of these conditions is likely underestimated due to the lack of shared clinical criteria and to the existence of several borderline clinical pictures. We will focus on the clinical and molecular diagnosis of the most common IPCDs, namely hypertrophic cardiomyopathies, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy, and left ventricular non-compaction. Collectively, these conditions account for the majority of SCD episodes and/or cardiologic clinical problems in athletes. In addition to the clinical and instrumental tools for the diagnosis of IPCD, the viral technological advances in genetic testing have facilitated the molecular confirmation of these conditions. However, genetic testing presents several issues: the limited sensitivity (globally, around 50%), the low prognostic predictive value, the probability to find pathogenic variants in different genes in the same patient, and the risk of non-interpretable results. In this review, we will analyze the pros and cons of the different clinical approaches for the presymptomatic identification, the diagnosis and management of IPCD athletes, and we will discuss the indications to the genetic testing for patients and their relatives, particularly focusing on the most complex scenarios, such as presymptomatic tests, uncertain results, and unexpected findings.

KEYWORDS:

arrhythmogenic right ventricular displasia; athletes; genetics; hypertrophic cardiomyopathy; isolated non-compact myocardium; long QT syndrome; medical; sudden cardiac death

PMID:

 

27617263

 

PMCID:

 

PMC5000131

 

DOI:

 

10.3389/fcvm.2016.00028

[PubMed] 

Free PMC Article

Public Health Genomics Knowledge Base (v1.2)

SUDDEN DEATH

Last Updated: Oct 20, 2016

• The Role of Genetic Testing in the Identification of Young Athletes with Inherited Primitive Cardiac Disorders at Risk of Exercise Sudden Death.
  Tiziano Francesco Danilo et al. Frontiers in cardiovascular medicine 2016 328
• Associations of Prolonged QTc in Sickle Cell Disease.
  Indik Julia H, et al. PloS one 2016 0 (10) e0164526
• Sudden Death in the Young (SDY) Case Registry 
• Molecular Autopsies ID Genetic Suspects in Cases of Sudden Death
  GEN News Highlights, October 12, 2016
• Sudden death and cardiac arrest without phenotype: the utility of genetic testing.
  Wijeyeratne Yanushi D et al. Trends in cardiovascular medicine 2016 Aug
• Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting
  S Christainsen et al, Eur J Hum Genetics, September 21, 2016
• β-Blocker Adherence in Familial Long QT Syndrome.
  Waddell-Smith Kathryn E et al. Circulation. Arrhythmia and electrophysiology 2016 Aug 9(8)
• Evaluation and Management of Athletes With Long QT Syndrome: An Evolved Paradigm.
  Gomez Andrew T et al. Sports health 2016 Aug
• The Canadian Arrhythmogenic Right Ventricular Cardiomyopathy Registry: Rationale, Design, and Preliminary Recruitment.
  Krahn Andrew D, et al. The Canadian journal of cardiology 2016 4
• Postmortem genetic screening for the identification, verification, and reporting of genetic variants contributing to the sudden death of the young.
  Methner D Nicole Riherd et al. Genome research 2016 Jul
• Ethics, Guidelines for Molecular Autopsy in Youth Sudden Death Explored by Texas Team,
  Genome Web, July 15, 2016
• Morphologic features of culprit lesions in sudden coronary death with family history of premature coronary artery disease.
  Zhang Ming Chang et al. Forensic science international 2016 Jul 266412-415
• The ethics of conducting molecular autopsies in the cases of sudden death in the young.
  McGuire Amy et al. Genome research 2016 Jul
• Beer Drinking Associates with Lower Burden of Amyloid Beta Aggregation in the Brain: Helsinki Sudden Death Series.
  Kok Eloise H, et al. Alcoholism, clinical and experimental research 2016 5
• How genetic sequencing can unlock secret DNA mutations — and save lives
  PBS Newshour, May 13, 2016

• CDC Information (2)
• CDC-Authored Pub (1)

• Human (9)
• Pathogen (0)

• Human (369)
• Pathogen (0)

• Human (21)
• Pathogen (0)

• Guidelines (0)
• Tier Table (0)
• Synthesis (2)

• Huamn (6)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB